Short-time Safety of the Sinopharm COVID-19 Vaccine in Patients with Hemophilia
| Author | Meysam Yousefi | en |
| Author | Reza Sinaei | en |
| Author | Amirabbass Shafiei Zadeh | en |
| Author | Mehrdad Farrokhnia | en |
| Author | Behnam Dalfardi | en |
| Orcid | Meysam Yousefi [0000-0002-1332-6670] | en |
| Orcid | Reza Sinaei [0000-0002-2702-5836] | en |
| Orcid | Behnam Dalfardi [0000-0003-4547-0965] | en |
| Issued Date | 2021-12-31 | en |
| Abstract | Background: The COVID-19 pandemic, caused by SARS-Cov-2, has affected the care of patients with hemophilia, indicating the necessity of their vaccination. Nevertheless, there are concerns about using anti-SARS-Cov-2 virus vaccines for hemophilic patients, particularly concerning bleeding adverse events. Methods: Following a cross-sectional design, all adult hemophilic patients who received two doses of Sinopharm anti-SARS-Cov-2 virus vaccine in Afzalipour Hospital, Kerman, Iran, during May and June 2021 were recruited. The participants were followed for two weeks after receiving each dose of vaccine. Results: Fifty-one patients with a mean age of 37.07 ± 11.45 years were included, of whom 27 (61.4 %) patients experienced at least one adverse reaction. Pain was the most frequent local adverse event (occurred in 20 (39.2%) and 15 (29.4%) cases after 1st and 2nd doses, respectively). Menometrorrhagia and epistaxis were reported by two and one patients, respectively. Conclusions: Overall Sinopharm anti-SARS-Cov-2 virus vaccine seems to be safe for patients with hemophilia in the short term. | en |
| DOI | https://doi.org/10.5812/archcid-122097 | en |
| Keyword | COVID-19 | en |
| Keyword | Drug Toxicity | en |
| Keyword | Hemophilia | en |
| Keyword | SARS-CoV-2 | en |
| Keyword | Vaccines | en |
| Publisher | Brieflands | en |
| Title | Short-time Safety of the Sinopharm COVID-19 Vaccine in Patients with Hemophilia | en |
| Type | Brief Report | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- archcid-16-6-122097.pdf
- Size:
- 101.28 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF